SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001088875-18-000006
Filing Date
2018-01-10
Accepted
2018-01-10 08:58:02
Documents
1

Document Format Files

Seq Description Document Type Size
1 Junotherapeutics12312017.txt SC 13G/A 9734
  Complete submission text file 0001088875-18-000006.txt   11230
Mailing Address CALTON SQUARE 1 GREENSIDE ROW EDINBURGH X0 EH13AN
Business Address CALTON SQUARE 1 GREENSIDE ROW EDINBURGH X0 EH13AN 00441312752000
BAILLIE GIFFORD & CO (Filed by) CIK: 0001088875 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0
Type: SC 13G/A

Mailing Address 400 DEXTER AVENUE NORTH, SUITE 1200 SEATTLE WA 98109
Business Address 400 DEXTER AVENUE NORTH, SUITE 1200 SEATTLE WA 98109 2065821600
Juno Therapeutics, Inc. (Subject) CIK: 0001594864 (see all company filings)

IRS No.: 463656275 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88476 | Film No.: 18520400
SIC: 2836 Biological Products, (No Diagnostic Substances)